StockWatch
·
Medical/Dental Instruments
BuybackMay 18, 2026, 07:22 AM

Boston Scientific Enters $2B Accelerated Share Repurchase

AI Summary

Boston Scientific Corporation announced it has entered into a $2 billion accelerated share repurchase (ASR) agreement with JPMorgan Chase Bank, National Association. This ASR is part of the company's previously authorized $5 billion share repurchase program. The company initially received approximately 30.4 million shares and expects the final settlement to be completed by June 30, 2026. The ASR is anticipated to be accretive to adjusted earnings per share by $0.02 for the full year 2026, with $3 billion remaining under the authorization after its completion.

Key Highlights

  • Boston Scientific entered a $2 billion accelerated share repurchase (ASR) agreement with JPMorgan Chase Bank.
  • The ASR is part of a previously announced $5 billion share repurchase authorization.
  • The company received approximately 30.4 million shares initially, based on a May 15, 2026 closing price of $52.68.
  • The final settlement of the ASR is expected to be completed by June 30, 2026.
  • Following the ASR, Boston Scientific will have $3 billion remaining under its share repurchase authorization.
  • The ASR is expected to have a $0.02 accretive net impact to adjusted earnings per share for full year 2026.